Sheraton National Hotel, Arlington, VA, USA
Sep 15 2011 7:00AM - Sep 16 2011 5:00PM
Improve All Aspects of the Design, Development, Manufacturing, and Regulation of Transdermal Drug Delivery Systems. The first US transdermal drug delivery system (TDDS) was approved by the FDA more than 30 years ago. Despite this length of time and the advancement of science in many other pharmaceutical fields, little has changed or evolved in the development, control and regulation of these products. Over the years, various product quality problems have been reported by patients and practitioners. Some of these quality problems have safety and efficacy implications that have led to the recall of numerous batches of products and, in some cases, the temporary or permanent removal of the product from the market. This FDA-cosponsored workshop will offer a multidisciplinary and crossfunctional look at TDDSs to improve the development, design, manufacturing, quality, clinical performance, safety and regulation of these products. Co-sponsored by FDA and DIA Event Code: 11021
|
|